Glucocorticoids Inhibit the Autoregulatory Induction of lnterleukin-1 in Monocytes after Endotoxin Stimulation

NeuroImmunoModulation

Volumn 3, Issue 4, 1996, Pages 227-232

  Paez Pereda, Marcelo ^a   Perez Castro, Carolina ^c   Costas, Monica ^a   Nahmod, Victor E ^a   Stalla, Günter K ^b   Holsboer, Florian ^b   Arzt, Eduardo ^a,c  

^a INSTITUTO DE INVESTIGACIONES MÉDICAS ALFREDO LANARI   (Argentina)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Endotoxin; Glucocorticoids; Interleukin l; Monocytes

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; HYDROCORTISONE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MESSENGER RNA; MIFEPRISTONE;

ADULT; ARTICLE; HUMAN; HUMAN CELL; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL;

CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTOXINS; GLUCOCORTICOIDS; HOMEOSTASIS; HUMANS; INTERLEUKIN-1; LIPOPOLYSACCHARIDES; MONOCYTES;

EID: 12644271901     PISSN: 10217401     EISSN: 14230216     Source Type: Journal    
DOI: 10.1159/000097275     Document Type: Article

References (36)

1. Dinarello CA: Interleukin-1 and interleukin-1 antagonism, Blood 1991;77:1627-1652.
2. Oppenheim JJ, Kovacs EJ, Matsushima K, Durum SK: There is more than one interleukin 1, Immunol Today 1986;7:45-56.
3. Dinarello CA, Ikejima T, Warner SJC, Oren-eole SF, Lonncmann G, Cannon JG, Libby P: Interleukin I induces interleukin 1, I, Induction of circulating interleukin I in rabbits in vivo and in human mononuclear cells in vitro, J Immunol 1987;139:1902-1910.
4. Warner SJC, Auger KR, Libby P: Intcrlcukin-I induces interleukin-1, II, Recombinant human interleukin-1 induces interleukin-1 production by adult human vascular endothelial cells, J Immunol 1987:139:1911-1917.
5. Warner SJC, Auger KR, Libby P: Human inter-lcukin-1 induces interleukin-1 gene expression in human vascular smooth muscle cells, J Exp Med 1987:165:1316-1331.
6. Dinarello CA: Role of interleukin-1 in infectious diseases, Immunol Rev 1992; 127:119-146.
7. Thompson RC, Dripps DJ, Eisenberg SP: Interleukin-! receptor antagonist (11.-Ira) as a probe and as a treatment for IL-1 mediated disease, Int J Immunopharmacol 1992;14:475-480.
8. Van Zee KJ, Coyle Calvano SM, Oldenburg HSA, Stiles DM, Pribble J, Catalano M, Mol-dawer LL, Lowry SF: Influence of IL-I receptor blockade on the human response to endotox-emia, J Immunol 1995;154:1499-1504.
9. Fisher E, Marano MA, Van Zee KJ, Rock CS, Hawes AS, Thompson WA, DeForge L, Kennedy JS, Rcmick DG, Bloedow DC, Thompson RC, Lowry SF, Moldawer LL: Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia, J Clin Invest 1992:89: 1551-1557.
10. Conti P, Panara MP, Fridas S, Barbacane RC, Grilli A, Placido FC, Reale M, Fiore S: Inhibition of granuloma formation induced by permanganate in the mouse by a specific human recombinant rcccptor antagonist for interleu-kin-1 (hrlL-lra), Cell Immunol 1993; 147:446.
11. Vidal-Vanadocha F, Amczaga C, Asumcndi A, Kaplanski G, Dinarello CA: Interleukin-1 receptor blockade reduces the number and size of murine BI6 melanoma hepatic mctastascs, Cancer Res 1994;54:2667-2672.
12. Eisenberg SP, Evans RJ, Arend WP, Verderber E, Brewer MT, Hannum CH, Thompson RC: Primary structure and functional expression from complementary DNA of a human inter-lcukin-1 receptor antagonist, Nature 1990:343: 341-346.
13. Granowiu EV, Clark BD, Vannier H, Callahan MV, Dinarello CA: Effect of interleukin-1 (IL-I) blockade on cytokine synthesis: I, IL-I rcccptor antagonist inhibits IL-l-induccd cytokine synthesis and blocks the binding of IL-1 to its tvpc II receptor on human monocytes, Blood 1992;79:2356-2363.
14. Evans RJ, Bray J, Childs JD, Vigcrs GPA, Brandhuber BJ, Skalicky JJ, Thompson RC, Eisenbcrg SP: Mapping rcccptor binding sites in interleukin (IL)-I rcccptor antagonist and IL-lp by site directed mutagenesis, J Biol Chcm 1995:270:11477-11483.
15. Colotta F, Re F, Muzio M, Bcrlini R, Polenta-rutti N, Sironi M, Giri JG, Dower SK, Sims JE, Mantovani A; lnterleukin-1 type 11 receptor: A decoy larger for IL-I that is regulated by IL-4, Science 1993;261:472-475.
16. Re F, Muzio M, De Rossi M, Polentarutti N, Mantovani A, Colotta F: The type II receptor as a decoy target for interleukin-1 in polymorphonuclear leukocytes: Characterization of induction by dexamethasone and ligand binding propert ies of the released decoy rcccptor, J Exp Med 1994;179:739-743.
17. Poutsiaka DD, Clark BD, Vannier E, Dinarello CA: Production of intcrlcukin-1 receptor antagonist and interleukin-1 5 by peripheral blood mononuclear cells is differentially regulated, Blood 1991;78:1275-1281.
18. Arend WP, Smith MF, Janson RW, Joslin FG: IL-1 rcccptor antagonist and IL-1 3 production in human monocytes are regulated differently, J Immunol 1991;147:1530-1536.
19. Andersson LB, Bjork L, Dinarello CA, Towbin H, Andersson U: Lipopolysaccharidc induces human interleukin-1 receptor antagonist and interleukin-1 production in the same cell, EurJ Immunol 1992;22:2617-2623.
20. Cupps TR, Fauci AS: Corticosteroid-mediated immunorcgulation in man, Immunol Rev 1982;65:133-155.
21. Snyder DS, Unanue ER: Corticosteroids inhibit murine macrophage la expression and interleukin I production, J Immunol 1982:129: 1803-1805.
22. Lee SW, Tsou AP, Chan H, Thomas J, Petrie K, Eugui EM, Allison AG: Glucocorticoids selectively inhibit the transcription of the interleukin ip gene and decrease the stability of interleukin ip mRNA, Proc Natl Acad Sci USA 1988;85:1204-1208.
23. Bcscdovsky H, del Rev A, Sorkin E, Dinarcl-lo CA: Immunorcgulatory feedback between interleukin-1 and glucocorticoid hormones, Science 1986;233:652-654.
24. Arzt E, Sauer J, Pollmacher T, Labeur M, llols-bocr F, Reul JMHM, Stalla GK: Glucocorticoids suppress interleukin-1 receptor antagonist synthesis follow ing induction by endotoxin, Endocrinology 1994;134:672-677.
25. Sauer J, Castren M, Hopfner U, Holsboer F, Stalla GK, Arzt E: Inhibition of lipopolysac-charide-induccd monocyte interleukin-1 rcccptor antagonist synthesis by cortisol: Involvement of the mineralocorticoid receptor, J Clin Endocrinol Metab 1996;81:73-79.
26. Arzt E, Fernández CS, Finocchiaro L, Criscuolo M, Diaz A, Finkielman S, Nahmod VE: Immunomodulation by indolcamincs: Serotonin and melatonin action on DNA and interferon gamma synthesis by human peripheral blood mononuclear cells, J Clin Immunol 1988;8:513-519.
27. Sayers G: The adrenal cortex and homeostasis, Physiol Rev 1950;30:241-320.
28. Schrcibcr W, Pollmacher T, Fassbcnder K, Gu-dcwill S, Vcdder H, Wiedemann K, Galanos C, Holsboer F: Endotoxin- and corticotropin-releasing hormone-induced release of ACTH and cortisol: A comparative study in men, Ncu-roendoerinology 1993:58:123-128.
29. Arzt E, Stclzer G, Renner U, Lange M, Müller OA, Stalla GK: Interleukin-2 and interleukin-2 rcccptor expression in human corticotrophic adenoma and murine pituitary cell cultures, J Clin Invest 1992;90:1944-1951.
30. Nishida T, Nishino N, Takano M, Kawai K, Bando K, Masui Y, Nakai S, Hirai Y: cDNA cloning of IL-I a and IL-ip from mRNA of U937 cell line, Biochcm Biophys Res Commun 1987;143:345-352.
31. Granowitz EV, Vannier E, Poutsiaka DD, Dinarello CA: Effect ofintcrleukin-1 (IL-1) blockade on cytokine synthesis: II, IL-l rcccptor antagonist inhibits lipopolysaccharide-induecd cytokinc synthesis by human monocytes, Blood 1992:79:2364-2369.
32. Ishikawa Y, Mukaida N, Kuno K, Rice N, Oka-moto S, Matsushima K: Establishment of lipo-polysaccharidc-dcpcndcnt nuclear factor kB activation in a cell-free system, J Biol Chem 1995:270:4158-4164.
33. McKcan DJ, Bell M, Huntoon C, Rastogi S, Van Norstrand M, Podzorski R, Nilson A, Paya C: IL-I rcccptor and TCR signals syner-gizc to activate NF-KB-mediatcd gene transcription, Int Immunol 1995;7:9-20.
34. Serkkola E, Hurme M: Synergism between pro-tcin-kinasc C and cAMP-dependent pathways in the expression of the interleukin-ip gene is mediated via the activator-protein-1 (AP-1) enhancer activity, EurJ Biochem 1993:213:243-249.
35. Albrightson CR, Bacnziger NL, Needleman P: Exaggerated human vascular cell prostaglandin biosynthesis mediated by monocytes: Role of monokines and interleukin 1, J Immunol 1985; 135:1872-1877.
36. Knudsen PJ, Dinarello CA, Strom TB: Prostaglandins posttranseriptionally inhibit mono-cvtc expression of interleukin I activity by increasing intracellular cyclic adenosine monophosphate, J Immunol 1986;137:3189-3194.